Home Capital Broker's Calls

SCCM positive on Cordlife as it posts FY2020 results 'in line' with expectations

Lim Hui Jie
Lim Hui Jie3/12/2021 04:25 PM GMT+08  • 3 min read
SCCM positive on Cordlife as it posts FY2020 results 'in line' with expectations
SCCM has maintained its "buy" call and raised its target price to 52 cents on the stock.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Soochow CSSD Capital Markets (SCCM) analyst Simeon Ang has maintained his “buy” call on Cordlife Group and raised his target price to 52 cents for the stock after its FY2020 results came in line with expectations.

Ang noted that Cordlife’s FY2020 Profit After Tax and Minority Interests (PATMI) came in flat at $6.5million, 1.2% higher y-o-y. This is due to higher operating margins, rising 1.6% y-o-y to 13.8% and lower tax expenses of almost 40% y-o-y.

However, revenue slid 17.8% y-o-y to $50.6 million on lower cord blood banking service demand in light of Covid-19, although diagnostics jumped 70% YoY.

×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.